Table 2:
Total Bleeding complications | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
In-Hospital mortality | Length of Stay (in days)** | Cost of Hospitalization (in dollars) | |||||||||
With bleeding complications No./Total (%) | Without bleeding complications No./Total (%) | p-value | Adjusted Odds Ratio* | p-Value | With bleeding complications | Without bleeding complications | p-value | With bleeding complications | Without bleeding complications | p-value | |
Cardiogenic shock with STEMI | 8616/31388 (27.4%) | 43432/14110 2 (30.8%) | <0.001 | 0.79 (0.77–0.81) | <0.001 | 15 | 10 | <0.001 | 210,258 | 139,409 | <0.001 |
CS with STEMI without MCS | 3810/12869 (29.4%) | 23652/68151 (34.7%) | <0.001 | 0.72 (0.69–0.75) | <0.001 | 14 | 8 | <0.001 | 166,063 | 95,576 | <0.001 |
CS with STEMI and IABP | 4106/16877 (24.3%) | 18268/69918 (26.1%) | <0.001 | 0.82 (0.79–0.86) | <0.001 | 14 | 11 | <0.001 | 155,176 | 220,107 | <0.001 |
CS with STEMI and PVAD | 201/603 (32.3%) | 653/1457 (44.8%) | <0.001 | 0.66 (0.52–0.83) | <0.001 | 18 | 13. | <0.001 | 403,242 | 265,020 | <0.001 |
CS with STEMI and ECMO | 122/241 (50.6%) | 126/203 (62.1%) | 0.01 | 0.67 (0.37–1.22) | 0.19 | 27 | 24 | 0.23 | 523,168 | 437,824 | 0.36 |
Adjusted for age, sex, race, smoking status, dyslipidemia, alcohol abuse, congestive heart failure, liver disease, peripheral vascular disease, deficiency anemia, chronic pulmonary disease, coagulopathy, renal failure diabetes, hypertension, cardiac arrest and vasopressor use.
included all patients that survived the index admission.